2020-12809. Proposed Data Collection Submitted for Public Comment and Recommendations  

  • Start Preamble

    AGENCY:

    Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

    ACTION:

    Notice with comment period.

    SUMMARY:

    The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on the CDC's National Healthcare Safety Network (NHSN). NHSN is a public health surveillance system that collects, analyzes, reports, and makes available data for monitoring, measuring, and responding to healthcare associated infections (HAIs), antimicrobial use and resistance, blood transfusion safety events, and the extent to which healthcare facilities adhere to infection prevention practices and antimicrobial stewardship.

    DATES:

    CDC must receive written comments on or before August 14, 2020.

    ADDRESSES:

    You may submit comments, identified by Docket No. CDC-2020-0065 by any of the following methods:

    • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments.
    • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS-D74, Atlanta, Georgia 30329.

    Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to Regulations.gov.

    Please note: Submit all comments through the Federal eRulemaking portal (regulations.gov) or by U.S. mail to the address listed above.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Start Printed Page 36208Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below.

    The OMB is particularly interested in comments that will help:

    1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;

    2. Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;

    3. Enhance the quality, utility, and clarity of the information to be collected; and

    4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses.

    5. Assess information collection costs.

    Proposed Project

    National Healthcare Safety Network (NHSN) (OMB Control No. 0920-0666)—Revision—National Center for Emerging and Zoonotic Infection Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).

    Background and Brief Description

    The Division of Healthcare Quality Promotion (DHQP), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC) collects data from healthcare facilities in the National Healthcare Safety Network (NHSN) under OMB Control Number 0920-0666. NHSN provides facilities, states, regions, and the nation with data necessary to identify problem areas, measure the progress of prevention efforts, and ultimately eliminate healthcare-associated infections (HAIs) nationwide. NHSN allows healthcare facilities to track blood safety errors and various healthcare-associated infection prevention practice methods such as healthcare personnel influenza vaccine status and corresponding infection control adherence rates.

    NHSN currently has six components: Patient Safety (PS), Healthcare Personnel Safety (HPS), Biovigilance (BV), Long-Term Care Facility (LTCF), Outpatient Procedure (OPC), and the Dialysis Component. NHSN's planned Neonatal Component is expected to launch during the winter of 2020/2021. This component will focus on premature neonates and the healthcare-associated events that occur as a result of their prematurity. This component will be released with one module, which includes Late Onset-Sepsis and Meningitis. Late-onset sepsis (LOS) and Meningitis are common complications of extreme prematurity. These infections are usually serious, causing a prolongation of hospital stay, increased cost, and risk of morbidity and mortality. The data for this module will be electronically submitted, and manual data entry will not be available. This will allow more hospital personnel to be available to care for patients and will reduce annual burden across healthcare facilities. Additionally, LOS data will be utilized for prevention initiatives.

    Data reported under the Patient Safety Component are used to determine the magnitude of the healthcare-associated adverse events and trends in the rates of the events, in the distribution of pathogens, and in the adherence to prevention practices. Data will help detect changes in the epidemiology of adverse events resulting from new medical therapies and changing patient risks. Additionally, reported data is being used to describe the epidemiology of antimicrobial use and resistance and to better understand the relationship of antimicrobial therapy to this rising problem.

    Approved as a New Emergency ICR (National Healthcare Safety Network (NHSN) Patient Impact Module for Coronavirus (COVID-19) Surveillance in Healthcare Facilities, OMB Control No. 0920-1290), NHSN launched a COVID-19 Module in the Patient Safety Component on March 27th, 2020. This Module is designed to collect facility-level COVID-19 data on cases, deaths, capacity, healthcare worker staffing shortages, and personal protective equipment and supplies from hospitals on a daily basis. Facility-level data collected through NSHN as part of the COVID-19 Module are being made available to a broader set of Federal, state, and local agency data users than data typically collected by NHSN. Specifically, COVID-19 data at the state, county, territory, and facility level submitted to NHSN will continue to be used for public health emergency response activities by CDC's emergency COVID-19 response, by the U.S. Department of Health and Human Services' (HHS') COVID-19 tracking system maintained in the Office of the Assistant Secretary of Preparedness and Response as part of the National Response Coordination Center at the Federal Emergency Management Agency (FEMA), and by the White House Coronavirus Task Force.

    Under the Healthcare Personnel Safety Component, protocols and data on events—both positive and adverse—are used to determine (1) the magnitude of adverse events in healthcare personnel, and (2) compliance with immunization and sharps injuries safety guidelines. Under the Biovigilance Component, data on adverse reactions and incidents associated with blood transfusions are reported and analyzed to provide national estimates of adverse reactions and incidents. Under the Long-Term Care Facility Component, data is captured from skilled nursing facilities. Reporting methods under the LTCF component have been created by using forms from the PS Component as a model with modifications to specifically address the specific characteristics of LTCF residents and the unique data needs of these facilities reporting into NHSN. A new form has been introduced for field testing- Respiratory Tract Infection (RTI)—not to be used by NHSN users, but as part of an EIP project with 4 EIP sites. Form title will be Denominators for Healthcare Associated Infections (HAIs): Respiratory Tract Infections. The purpose of this form is to allow testing prior to introducing a new module and forms to NHSN users. The CDC's Epidemiology Research & Innovations Branch (ERIB) team will use the form to perform field testing of variables to explore the utilization, applicability, and data collection burden associated with these variables. This process will inform areas of improvement prior to incorporating the new module, including protocol, forms, and instructions into NHSN. The estimated burden for this form is 20 minutes, which is based on a similar denominator form. Also approved under New Emergency ICR 0920-1290, NHSN Start Printed Page 36209launched a COVID-19 Module in the Long-Term Care Component April 27th, 2020. As with the COVID-19 Module in the PS Component, the LTC COVID-19 Module is designed to collect facility-level COVID-19 data on cases, deaths, capacity, healthcare worker staffing shortages, and personal protective equipment and supplies from long-term care facilities on at least a weekly basis. Facility-level data collected through NSHN as part of the COVID-19 Module are being made available to a broader set of Federal, state, and local agency data users than data typically collected by NHSN. Specifically, COVID-19 data at the state, county, territory, and facility level submitted to NHSN will continue to be used for public health emergency response activities by CDC's emergency COVID-19 response, by the U.S. Department of Health and Human Services' (HHS') COVID-19 tracking system maintained in the Office of the Assistant Secretary of Preparedness and Response as part of the National Response Coordination Center at the Federal Emergency Management Agency (FEMA), and by the White House Coronavirus Task Force.

    The Dialysis Component offers a simplified user interface for dialysis users to streamline their data entry and analyses processes as well as provide options for expanding in the future to include dialysis surveillance in settings other than outpatient facilities. The Outpatient Procedure Component (OPC) gathers data on the impact of infections and outcomes related to operative procedures performed in Ambulatory Surgery Centers (ASCs). The OPC is used to monitor two event types: Same Day Outcome Measures and Surgical Site Infections (SSIs). NHSN has increasingly served as the operating system for HAI reporting compliance through legislation established by the states. As of April 2020, 36 states, the District of Columbia and the City of Philadelphia, Pennsylvania have opted to use NHSN as their primary system for mandated reporting. Reporting compliance is completed by healthcare facilities in their respective jurisdictions, with emphasis on those states and municipalities acquiring varying consequences for failure to use NHSN. Additionally, healthcare facilities in five U.S. territories (Puerto Rico, American Samoa, the U.S. Virgin Islands, Guam, and the Northern Mariana Islands) are voluntarily reporting to NHSN. Additional territories are projected to follow with similar use of NHSN for reporting purposes.

    NHSN's data is used to aid in the tracking of HAIs and guide infection prevention activities/practices that protect patients. The Centers for Medicare and Medicaid Services (CMS) and other payers use these data to determine incentives for performance at healthcare facilities across the US and surrounding territories, and members of the public may use some protected data to inform their selection among available providers. Each of these parties is dependent on the completeness and accuracy of the data. CDC and CMS work closely and are fully committed to ensuring complete and accurate reporting, which are critical for protecting patients and guiding national, state, and local prevention priorities.

    CMS collects some HAI data and healthcare personnel influenza vaccination summary data, which is done on a voluntary basis as part of its Fee-for-Service Medicare quality reporting programs, while others may report data required by a federal mandate. Facilities that fail to report quality measure data are subject to partial payment reduction in the applicable Medicare Fee-for-Service payment system. CMS links their quality reporting to payment for Medicare-eligible acute care hospitals, inpatient rehabilitation facilities, long-term acute care facilities, oncology hospitals, inpatient psychiatric facilities, dialysis facilities, and ambulatory surgery centers. Facilities report HAI data and healthcare personnel influenza vaccination summary data to CMS via NHSN as part of CMS's quality reporting programs to receive full payment. Still, many healthcare facilities, even in states without HAI reporting legislation, submit limited HAI data to NHSN voluntarily. NHSN's data collection updates continue to support the incentive programs managed by CMS. For example, survey questions support requirements for CMS' quality reporting programs. Additionally, CDC has collaborated with CMS on a voluntary National Nursing Home Quality Collaborative, which focuses on recruiting nursing homes to report HAI data to NHSN and to retain their continued participation. This project has resulted in a significant increase in long-term care facilities reporting to NHSN.

    The ICR previously approved in December of 2019 for 5,352,360 responses; 3,113,631 burden hours. The proposed changes in this new ICR include revisions to eight data collection forms and the addition of ten new forms for a total of 86 proposed data collection forms. In this Revision, CDC requests OMB approval for an estimated 2,365,743 annual burden hours.

    Estimated Annualized Burden Hours

    Form No. & nameNumber of respondentsNumber of responses per respondentAverage burden per response (min./hour)Total burden (hours)
    57.100 NHSN Registration Form2,00015/60167
    57.101 Facility Contact Information2,000110/60333
    57.103 Patient Safety Component—Annual Hospital Survey6,765155/606,201
    57.105 Group Contact Information1,00015/6083
    57.106 Patient Safety Monthly Reporting Plan7,8211215/6023,463
    57.108 Primary Bloodstream Infection (BSI)5,775538/6018,288
    57.111 Pneumonia (PNEU)1,800230/6018,288
    57.112 Ventilator-Associated Event5,463828/6020,395
    57.113 Pediatric Ventilator-Associated Event (PedVAE)334130/60167
    57.114 Urinary Tract Infection (UTI)6,000520/6010,000
    57.115 Custom Event6009135/6031,850
    57.116 Denominators for Neonatal Intensive Care Unit (NICU)1,100124/60880
    57.117 Denominators for Specialty Care Area (SCA)/Oncology (ONC)500125/60503
    57.118 Denominators for Intensive Care Unit (ICU)/Other locations (not NICU or SCA)5,500605/6027,665
    57.120 Surgical Site Infection (SSI)6,000935/6031,500
    Start Printed Page 36210
    57.121 Denominator for Procedure6,00060210/60602,000
    57.122 HAI Progress Report State Health Department Survey55128/6026
    57.123 Antimicrobial Use and Resistance (AUR)-Microbiology Data Electronic Upload Specification Tables2,500125/601,500
    57.124 Antimicrobial Use and Resistance (AUR)-Pharmacy Data Electronic Upload Specification Tables2,000125/602,000
    57.125 Central Line Insertion Practices Adherence Monitoring50021325/6044,375
    57.126 MDRO or CDI Infection Form7201230/603,960
    57.127 MDRO and CDI Prevention Process and Outcome Measures Monthly Monitoring5,5002915/6039,875
    57.128 Laboratory-identified MDRO or CDI Event4,8007920/60126,400
    57.129 Adult Sepsis5025025/605,208
    57.130 COVID-19 Module: Patient Impact and Hospital Capacity3,11754025/60701,325
    57.131 COVID-19 Module: Healthcare Worker Staffing3,11754025/60701,325
    57.132 COVID-19 Module: Supplies3,11754025/60701,325
    57.135 Late Onset Sepsis/Meningitis Denominator Form: Data Table for monthly electronic upload300125/60300
    57.136 Late Onset Sepsis/Meningitis Event Form: Data Table for Monthly Electronic Upload30045/60100
    57.137 Long-Term Care Facility Component—Annual Facility Survey3,07911/6051
    57.138 Laboratory-identified MDRO or CDI Event for LTCF1,9982412/609,590
    57.139 MDRO and CDI Prevention Process Measures Monthly Monitoring for LTCF1,9981212/604,795
    57.140 Urinary Tract Infection (UTI) for LTCF3391212/60814
    57.141 Monthly Reporting Plan for LTCF2,0111212/604,826
    57.142 Denominators for LTCF Locations33912250/60814
    57.143 Prevention Process Measures Monthly Monitoring for LTCF1301212/60312
    57.144 LTCF COVID-19 Module: Resident Impact and Facility Capacity14,6742620/60127,175
    57.145 LTCF COVID-19 Module: Staff and Personnel Impact14,6742615/6095,381
    57.146 LTCF COVID-19 Module: Supplies and PPE14,674265/6031,794
    57.147 LTCF COVID-19 Module: Ventilator Capacity and Supplies14,674265/6031,794
    57.150 LTAC Annual Survey620110/6010
    57.151 Rehab Annual Survey1,340110/60625
    57.200 Healthcare Personnel Safety Component Annual Facility Survey501480/60400
    57.203 Healthcare Personnel Safety Monthly Reporting Plan15/60
    57.204 Healthcare Worker Demographic Data5020020/603,333
    57.205 Exposure to Blood/Body Fluids505060/602,500
    57.206 Healthcare Worker Prophylaxis/Treatment503015/60375
    57.207 Follow-Up Laboratory Testing505015/60625
    57.210 Healthcare Worker Prophylaxis/Treatment-Influenza505010/60417
    57.300 Hemovigilance Module Annual Survey500185/60708
    57.301 Hemovigilance Module Monthly Reporting Plan500121/60100
    57.303 Hemovigilance Module Monthly Reporting Denominators5001270/607,000
    57.305 Hemovigilance Incident5001010/60833
    57.306 Hemovigilance Module Annual Survey—Non-acute care facility500135/60292
    57.307 Hemovigilance Adverse Reaction—Acute Hemolytic Transfusion Reaction500420/60667
    57.308 Hemovigilance Adverse Reaction—Allergic Transfusion Reaction500420/60667
    57.309 Hemovigilance Adverse Reaction—Delayed Hemolytic Transfusion Reaction500120/60167
    57.310 Hemovigilance Adverse Reaction—Delayed Serologic Transfusion Reaction500220/60333
    57.311 Hemovigilance Adverse Reaction—Febrile Non-hemolytic Transfusion Reaction500420/60667
    57.312 Hemovigilance Adverse Reaction—Hypotensive Transfusion Reaction500120/60167
    57.313 Hemovigilance Adverse Reaction—Infection500120/60167
    57.314 Hemovigilance Adverse Reaction—Post Transfusion Purpura500120/60167
    57.315 Hemovigilance Adverse Reaction—Transfusion Associated Dyspnea500120/60167
    57.316 Hemovigilance Adverse Reaction—Transfusion Associated Graft vs. Host Disease500120/60167
    57.317 Hemovigilance Adverse Reaction—Transfusion Related Acute Lung Injury500120/60167
    57.318 Hemovigilance Adverse Reaction—Transfusion Associated Circulatory Overload500220/60333
    57.319 Hemovigilance Adverse Reaction—Unknown Transfusion Reaction500120/60167
    57.320 Hemovigilance Adverse Reaction—Other Transfusion Reaction500120/60167
    57.400 Outpatient Procedure Component—Annual Facility Survey700110/60117
    57.401 Outpatient Procedure Component—Monthly Reporting Plan7001215/602,100
    Start Printed Page 36211
    57.402 Outpatient Procedure Component Same Day Outcome Measures200140/60133
    57.403 Outpatient Procedure Component—Monthly Denominators for Same Day Outcome Measures20040040/6053,333
    57.404 Outpatient Procedure Component—SSI Denominator70010040/6046,667
    57.405 Outpatient Procedure Component—Surgical Site (SSI) Event700540/602,333
    57.500 Outpatient Dialysis Center Practices Survey7,2001127/6015,240
    57.501 Dialysis Monthly Reporting Plan7,200125/607,200
    57.502 Dialysis Event7,2003025/6090,000
    57.503 Denominator for Outpatient Dialysis7,2003010/6014,400
    57.504 Prevention Process Measures Monthly Monitoring for Dialysis1,7301275/6025,950
    57.505 Dialysis Patient Influenza Vaccination6155010/605,125
    57.506 Dialysis Patient Influenza Vaccination Denominator615510/60513
    57.507 Home Dialysis Center Practices Survey430130/60215
    Total2,365,743
    Start Signature

    Jeffrey M. Zirger,

    Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention.

    End Signature End Supplemental Information

    [FR Doc. 2020-12809 Filed 6-12-20; 8:45 am]

    BILLING CODE 4163-18-P

Document Information

Published:
06/15/2020
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Action:
Notice with comment period.
Document Number:
2020-12809
Dates:
CDC must receive written comments on or before August 14, 2020.
Pages:
36207-36211 (5 pages)
Docket Numbers:
60Day-20-0666, Docket No. CDC-2020-0065
PDF File:
2020-12809.Pdf